Chiesi, Protalix’s PRX-102 secure FDA nod to treat Fabry disease

PRX-102 is indicated to treat Fabry disease in adult patients. Credit: ProteinBoxBot at English Wikipedia/ commons.wikimedia.org.



  • Chiesi